Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Robert Califf Kenneth W Mahaffey Graeme J. Hankey Shaun G Goodman Scott D Berkowitz Harvey White Günter Breithardt Daniel E. Singer Jonathan L. Halperin Jonathan P. Piccini Christopher C Nessel Daniel Wojdyla Matthew W Sherwood |
| Publication date | December 4, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |